Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malva sylvestris mouthwash for chemotherapy-induced stomatitis
IRCT20150713023190N15Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Aug 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mallow extract in chemotherapy-induced stomatitis, sponsored by Rafsanjan University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
mallow extract
03
Conditions
chemotherapy-induced stomatitis
Beyond the preview
Go deeper on IRCT20150713023190N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150713023190N15.